STX2 and hemolytic-uremic syndrome: However, in 5–7% of infected persons, the infection leads to a systemic, sometimes life-threatening complication known as HUS, a development which is mediated by the bacterial expression of Shiga toxins, Stx1 and Stx2, encoded by the stx1 and stx2 genes5–8.